Navigation Links
TWO NEW KLRI PEER-REVIEWED PUBLICATIONS: Hormone Therapy May Reduce Atherosclerosis in Women Close to Menopause; Growth Hormone May Increase Risk of Diabetes, Improve Lipid Profile in Men
Date:8/3/2009

arch Institute

Kronos Longevity Research Institute (KLRI) is a not-for-profit, 501(c)(3) organization that conducts state-of-the-art clinical translational research on the prevention of age-related diseases and the extension of healthier human life. KLRI tests new strategies to detect and prevent chronic diseases associated with aging and investigates the effects of innovative interventions to slow the aging process and improve health outcomes for older persons. In addition, KLRI helps the medical and lay communities understand important aging issues. KLRI research findings support a healthier quality of life and a robust lifestyle in our senior years. For more information, visit www.kronosinstitute.org.


'/>"/>
SOURCE Kronos Longevity Research Institute
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Halozyme Therapeutics Announces Peer-Reviewed Publications of the INFUSE-LR Clinical Trial Results and Clinical Practice Experience With Hylenex
2. Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
3. Emisphere Technologies Announces the Launch of a Human Clinical Trial For Oral Parathyroid Hormone (PTH)
4. Poniard Announces Positive First-Line Efficacy and Safety Data From Ongoing Phase 2 Trial of Picoplatin in Patients with Metastatic Hormone Refractory Prostate Cancer
5. Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95% and Halts Metastasis in a Model of Hormone-Refractory Prostate Cancer
6. Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble
7. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
8. Obesity-Related Hormone is Higher in Children with Down Syndrome
9. Study Results Show That Minimally Invasive Therapy is Successful for Over Two-Thirds of Stroke Patients Treated Outside the Standard Eight-Hour Window
10. Study Shows Cancer Vaccines Led to Long-Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of Therapy
11. First Skin Cancer Patients Treated With Electronic Brachytherapy (eBx) At University of Wisconsin Riverview Cancer Center

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)..., NEWYORK,Nov.23/PRNewswire/--Reportlinker.coman...scatalogue. ,, HolterMonitoringSystems-AGlobal...p0164324/Holter-Monitoring-Systems---A-Global-Mark...m=pr&utm_campaign=prnewswire ,, Cardiov...tients.High-riskpatientsneedtobecontinuouslymonito...
(Date:11/23/2009)..., MINNEAPOLIS,Nov.23/PRNewswire/--BridgePointMed...formiteEuropeene)foritscoronaryandperipheralChroni...ossBoss(TM)CTOCrossingCatheterandtheStingray®...nterventionalcathetersthataredesignedtonavigatehig...ationviaangioplastyandstenting. ,, TheNationalH...
(Date:11/23/2009)..., ATLANTA,Nov.23/PRNewswire-FirstCall/-- CryoLif...deviceandcardiovasculartissueprocessingcompany,ann...mingPiperJaffray21stAnnualHealthCareConferenceatTh....Anderson,presidentandchiefexecutiveofficerofCryoL...oLifeandrecentdevelopmentsandhostaquestionandanswe...
Breaking Medicine Technology:Reportlinker Adds Holter Monitoring Systems - A Global Market Review 2Reportlinker Adds Holter Monitoring Systems - A Global Market Review 3Reportlinker Adds Holter Monitoring Systems - A Global Market Review 4Reportlinker Adds Holter Monitoring Systems - A Global Market Review 5BridgePoint Medical(R) Receives European CE Mark for Stingray(R) and CrossBoss(TM) for Opening Completely Blocked Arteries 2CryoLife to Present at 21st Annual Piper Jaffray Health Care Conference 2New England Business Offers Free Service to Companies in Need 57726 1New England Business Offers Free Service to Companies in Need 57726 2Vestara and MedClean Technologies Announce Co Marketing Partnership to Expand Innovative Solution for Pharmaceutical Waste Management 57724 1Vestara and MedClean Technologies Announce Co Marketing Partnership to Expand Innovative Solution for Pharmaceutical Waste Management 57724 2Vestara and MedClean Technologies Announce Co Marketing Partnership to Expand Innovative Solution for Pharmaceutical Waste Management 57724 3Image guided treatment for deep venous thrombosis could improve patients long term outcomes 57722 1Image guided treatment for deep venous thrombosis could improve patients long term outcomes 57722 2
...nd research for,mechanical circulatory support in ...(NIH) National Heart, Lung, and Blood Institute (N...e discussed at the International Society,for Heart...ing and,Scientific Sessions. The meeting is ongoin...d Hynes Convention Center., The use of mechanical...
...ol(TM), test results, SAN DIEGO, April 9, 2008 T...gy Annual Meeting suggest that an all-natural diet...th type 2 diabetes lower,their blood glucose numbe... Mal Evans, DVM, MSc, PhD, KGK Synergize Inc.,s S...ated testing has consistently shown that,Diabetino...
Other Medicine Technology:New Research for Mechanical Support Devices in Pediatrics to Be Released at International Heart and Lung Transplant Meeting 2People With Diabetes May Have All-Natural Citrus Supplement To Help Lower Blood Glucose and Cholesterol Levels 2People With Diabetes May Have All-Natural Citrus Supplement To Help Lower Blood Glucose and Cholesterol Levels 3
(Date:11/23/2009)...ipswithMinorityBanksin Washington D.C. , New...ntendedtoSpurEconomicGrowthandRevitalization ,...Vita,thenation,sleadingproviderofdialysisservices,...tiacommunityfora$1millioninvestmentinIndustrialBan...munities. ,, DaVita,sinvestmentinWashington,D.C...
(Date:11/23/2009)...ipswithMinorityBanksin Washington D.C. , New...mbia , S.C. IntendedtoSpurEconomicGrowthandRevi...ewswire/--DaVita,thenation,sleadingproviderofdialy...nitiativedesignedtocreatejobsandspurrevitalization...tsinleadingcommunityandminority-ownedbanks.DaVitah...
(Date:11/23/2009)... Alliance ProgramSupportsFutureLeadersinSTEMFiel...t www.Allia n ceS c holars.org ,....President,youcancountusin.Withourcommunity,founda...rtofEducatetoInnovate,"saidAdolphP.Falcon,SeniorVi...afterattendingaWhiteHousemeetingtodaywherePresiden...
(Date:11/23/2009)...,Nov.23/PRNewswire-USNewswire/-- The AmericanLegi...dividualmembershipassociationofstatelegislators,co...tt forpre-filinga constitutionalamendment toprotec...ces.SouthCarolinanowbecomesthe24thstatewherelegisl...eledafterALEC,s FreedomofChoiceinHealthCareAct . ,...
(Date:11/23/2009)...N,N.Y.,Nov.23/PRNewswire-USNewswire/--SouthamptonH...nated$5milliontofundanewEmergencyDepartment.Thegif...eHospitaltoalmostdoubletheexistingspaceandgreatlye...orsoftheSouthForkofLongIsland. ,, Scheduledforc...yDepartment willprovideacentralizedtraumanurses,st...
Breaking Medicine News(10 mins):Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 2Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 3Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 4Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 2Health News:DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country 3Health News:Alliance Joins President Obama at White House in Commitment to Science, Technology, Engineering, and Math (STEM) Education 2Health News:South Carolina Now 24th State to Defend Health Care Choice 2Health News:Southampton Hospital Receives $5 Million Gift for New Emergency Department 2
...e 16 BlueCross BlueShield,of South Carolina this ...f,the company,s health insurance plans that also a...viduals seeking more options., "With increasing h..." said BlueCross BlueShield Division President,Dav...
....D., director of the Duke Comprehensive Cancer Cen...ational Cancer Advisory Board. , Lyerly was one ... 2008. , The National Cancer Advisory Board is an...an Services and the director of the NCI on issues...
...IMMEDIATE RELEASE , Coffee,s aroma kick-starts g...od Chemistry , Drink coffee to send a wake-up ca...a? An international group of scientists is reporti...ound that coffee aroma orchestrates the expression...
...grated preclinical contract research provider base...leading early phase clinical trial facility in Aus...e alliance aims to enhance the delivery of bioanal...s, which are both commercialisation enterprises of...
...ntrol of risk factors, less likely to get choleste...lthDay News) -- Women with type 2 diabetes and hea...ment they need than men, making their ability to c...ng in San Francisco, probably explains why death f...
... Allows Verus to Focus Solely on AstraZeneca ...June 16 Verus Pharmaceuticals, Inc., a,pediatric-...ed today that,Meritage Pharma, Inc., a newly forme...ovel formulation of an existing,molecule intended ...
Other Medicine News:Health News:S.C. BlueCross Launches Less-Costly Plans Geared to Groups Seeking More Options 2Health News:American Chemical Society's Weekly PressPac: June 11, 2008 2Health News:American Chemical Society's Weekly PressPac: June 11, 2008 3Health News:American Chemical Society's Weekly PressPac: June 11, 2008 4Health News:American Chemical Society's Weekly PressPac: June 11, 2008 5Health News:American Chemical Society's Weekly PressPac: June 11, 2008 6Health News:American Chemical Society's Weekly PressPac: June 11, 2008 7Health News:American Chemical Society's Weekly PressPac: June 11, 2008 8Health News:TetraQ and Q-Pharm form strategic alliance 2Health News:TetraQ and Q-Pharm form strategic alliance 3Health News:Less Intensive Treatment Given Diabetic Women With Heart Disease 2Health News:Verus Pharmaceuticals Announces Divestiture of Pediatric GI Development Program to Meritage Pharma 2Health News:Verus Pharmaceuticals Announces Divestiture of Pediatric GI Development Program to Meritage Pharma 3
Super Anchor and Instrumentation
Mini-Revo Suture Anchor System
...xis features 'proximal protection' -- providing co...removal, even in vessels with side branches. , ...uire the attachment or exchange of extra devices f...patible with all standard PTCA guidewires. ,...
... only truly dedicated electrophysiology system on ...e System incorporates Fischer's patented "C inside...patient support personnel the ultimate in patient ...the ceiling suspended EPX2 minimizes equipment foo...
Medicine Products: